Lupin Launches Diabetes Drug Combination in the US
Lupin launches dapagliflozin and metformin extended-release tablets in the US, offering a bioequivalent and cost-effective alternative for type 2 diabetes management.
Dapagliflozin | 22/04/2026 | By News Bureau
Lupin Secures US FDA Approval for Dapagliflozin Tablets in US
Lupin secures US FDA approval for Dapagliflozin Tablets 5 mg and 10 mg in the US, bioequivalent to Farxiga.
Dapagliflozin | 08/04/2026 | By News Bureau
Lupin Gets Tentative Approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets
Dapagliflozin and Saxagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Dapagliflozin | 05/01/2024 | By Manvi | 531
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy